| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Phenolic / Polyphenol Comparison Matrix including: -Gallic acid (GA) -Caffeic acid (CA) -Ferulic acid (FA) -Ellagic acid (EA) -DHCA (3,4-dihydroxycinnamic acid variant class) -HCAs (general hydroxycinnamic acids class) -Rosmarinic acid -Propolis (CAPE-rich context) -Perilla (rosmarinic-rich context) -Moringa -Date fruit extract True Phenolic Acids (GA, CA, FA, EA, DHCA, HCAs) -Core identity: redox modulators -Anti-inflammatory signature: NF-κB ↓ -Nrf2 activation common in normal tissue -Tumor cytotoxicity usually requires ≥10–50 µM -Bioavailability often limiting Polyphenol-Rich Extracts (Propolis, Perilla, Moringa, Date) -Effects depend on composition -Strongest NF-κB inhibition: Propolis (CAPE) -Strongest biphasic redox: Gallic, Caffeic -Weakest direct tumor evidence: Date fruit extractPhenolic / Polyphenol Comparison Matrix (Cancer-Focused Mechanistic Orientation)
|
| Source: HalifaxProj(inhibit) CGL-CS |
| Type: |
| Phosphatidylinositol 3-kinase (PtdIns3K or PI3K) is a family of enzymes that play a crucial role in cell signaling pathways, particularly in the regulation of cell growth, survival, and metabolism. The PI3K pathway is one of the most frequently altered pathways in human cancer.
Inhibition of the PI3K pathway has been explored as a therapeutic strategy for cancer treatment. Several PI3K inhibitors have been developed and are currently being tested in clinical trials. These inhibitors can target specific components of the pathway, such as PI3K, AKT, or mTOR. Class I phosphoinositide 3-kinase (PI3K) Class III PtdIns3K In contrast to the class III PtdIns3K as a positive regulator of autophagy, class I PI3K-AKT signaling has an opposing effect on the initiation of autophagy. PI3K inhibitors include: -Idelalisib , Copanlisib, Alpelisib -LY294002? -Wortmannin: potent PI3K inhibitor, has some associated toxicity. -Quercetin: -Curcumin -Resveratrol -Epigallocatechin Gallate (EGCG) |
| 7519- | Phen, | HCAs, | Neuroprotective role of phenolic acids: mechanistic insights into cognitive decline and neurodegenerative disorder |
| - | Review, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:393 Target#:252 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid